General Dentistry News

Dentistry

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Lewis M – Medical interventions for patients with type 2 diabetes won't reduce health costs over the long term, according to a recently published study, but that doesn't mean they don't offer benefits.

Related Articles

Autosomal recessive familial neurohypophyseal diabetes insipidus - onset in early infancy
European Journal of Endocrinology, 11/10/09    Relevance Score: 67%

Diverse Vasopressin V2 Receptor Functionality Underlying Partial Congenital Nephrogenic Diabetes Insipidus
American Journal of Physiology: Renal Physiology, 10/08/09    Relevance Score: 65%

Vasopressin Type 2 Receptor V88M Mutation: Molecular Basis of Partial and Complete Nephrogenic Diabetes Insipidus
Nephron: Physiology, 10/08/09    Relevance Score: 65%

Challenges in management of patients with intracranial germ cell tumor and diabetes insipidus treated with cisplatin and/or ifosfamide based chemotherapy
Journal of Neuro-Oncology, 10/14/09    Relevance Score: 64%

Prevention of Type 2 Diabetes: Risk Status, Clinic, and Community
Journal of General Internal Medicine, 11/09/09    Relevance Score: 48%

Today in Economics of Medicine...keeping you current

Rising mortality and life expectancy differentials by lifetime earnings in the United States
Journal of Health Economics, 11/24/09

Hospital ownership and medical services: Market mix, spillover effects, and nonprofit objectives
Journal of Health Economics, 11/24/09

Pharmaceutical cost control in primary care: opinion and contributions by healthcare professionals
BMC Health Services Research, 11/23/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address